Aegerion Pharmaceuticals Inc (AEGR) financial statements (2022 and earlier)

Company profile

Business Address ONE MAIN STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments64,501375,937126,23182,177
Cash and cash equivalents64,501375,93761,01137,171
Short-term investments  65,22045,006
Receivables13,55717,1257,572 
Inventory, net of allowances, customer advances and progress billings58,7069,5101,640
Inventory58,7069,5101,640 
Prepaid expense and other current assets1,571
Other undisclosed current assets39,1744,8525,071 
Total current assets:175,938407,424140,51483,748
Noncurrent Assets
Property, plant and equipment4,8934,7111,6541,143
Intangible assets, net (including goodwill)252,517 
Goodwill9,600   
Intangible assets, net (excluding goodwill)242,917   
Restricted cash and investments   105
Other noncurrent assets8505,322164
Prepaid expense and other noncurrent assets93
Total noncurrent assets:258,26010,0331,8181,341
TOTAL ASSETS:434,198417,457142,33285,089
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities61,88743,53828,94518,009
Accounts payable10,7849,7134,1394,953
Accrued liabilities51,10326,64817,1278,951
Employee-related liabilities 7,1777,6794,105
Debt 3,4563,5783,022
Other undisclosed current liabilities25,000(7,177)(7,679)(4,105)
Total current liabilities:86,88739,81724,84416,926
Noncurrent Liabilities
Long-term debt and lease obligation229,7825554,011 
Long-term debt, excluding current maturities229,7825554,011 
Liabilities, other than long-term debt1,984179  
Deferred tax liabilities, net 179  
Other liabilities1,984   
Other undisclosed noncurrent liabilities 216,6104457,762
Total noncurrent liabilities:231,766217,3444,4567,762
Total liabilities:318,653257,16129,30024,688
Stockholders' equity
Stockholders' equity attributable to parent115,545160,296113,03260,401
Common stock31302925
Treasury stock, value(35,000)(35,000)  
Common stock, share subscribed but unissued, subscriptions receivable   (129)
Additional paid in capital519,166490,994369,055253,210
Accumulated other comprehensive income (loss)152(263)2817
Accumulated deficit(368,804)(295,465)(256,080)(192,722)
Total stockholders' equity:115,545160,296113,03260,401
TOTAL LIABILITIES AND EQUITY:434,198417,457142,33285,089

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
239,887158,37348,546 
Cost of revenue
(Cost of Goods and Services Sold)
(52,332)(15,918)(5,244) 
Gross profit:187,555142,45543,302 
Operating expenses(232,741)(170,705)(105,874)(60,607)
Other undisclosed operating income 1,548225 
Operating loss:(45,186)(26,702)(62,347)(60,607)
Nonoperating income (expense)1,221(1,847)58(721)
Investment income, nonoperating 246269162
Other nonoperating income (expense)1,221(2,093)(211)(883)
Interest and debt expense(27,605)(9,937)(722)(1,703)
Other undisclosed income from continuing operations before equity method investments, income taxes   766
Loss from continuing operations before income taxes:(71,570)(38,486)(63,011)(62,265)
Income tax expense(1,769)(899)(347) 
Net loss available to common stockholders, diluted:(73,339)(39,385)(63,358)(62,265)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(73,339)(39,385)(63,358)(62,265)
Other comprehensive income   65
Comprehensive loss:(73,339)(39,385)(63,358)(62,200)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent415(291)11 
Comprehensive loss, net of tax, attributable to parent:(72,924)(39,676)(63,347)(62,200)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: